These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31720955)

  • 21. The impact of self-selection based on HIV risk on the cost-effectiveness of preexposure prophylaxis in South Africa.
    Jamieson L; Gomez GB; Rebe K; Brown B; Subedar H; Jenkins S; Shoko N; Bekker LG; Johnson LF; Meyer-Rath G
    AIDS; 2020 May; 34(6):883-891. PubMed ID: 32004205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing preferences for HIV pre-exposure prophylaxis (PrEP) delivery services via online pharmacies in Kenya: protocol for a discrete choice experiment.
    Chen Y; Saldarriaga EM; Montano MA; Ngure K; Thuo N; Kiptinness C; Rafferty M; Terris-Prestholt F; Stergachis A; Mugambi ML; Ortblad KF; Sharma M
    BMJ Open; 2023 Apr; 13(4):e069195. PubMed ID: 37012008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral and vaginal HIV pre-exposure prophylaxis product attribute preferences among female sex workers in the Mexico-US border region.
    Pines HA; Strathdee SA; Hendrix CW; Bristow CC; Harvey-Vera A; Magis-Rodríguez C; Martinez G; Semple SJ; Patterson TL
    Int J STD AIDS; 2019 Jan; 30(1):45-55. PubMed ID: 30170533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "We know this will be hard at the beginning, but better in the long term": understanding PrEP uptake in the general population in Eswatini.
    Bärnighausen K; Matse S; Hughey AB; Hettema A; Bärnighausen TW; McMahon SA
    AIDS Care; 2020 Feb; 32(2):267-273. PubMed ID: 31437021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How Male Sex Workers and Their Clients Shifted from Reluctance About HIV Pre-exposure Prophylaxis to Advocating for Its Use: A Longitudinal Mixed Methods Study.
    MacGibbon J; Minichiello V; Prestage G; Bell S; Cox C; Donovan B; Callander D
    AIDS Behav; 2020 Mar; 24(3):782-790. PubMed ID: 31367966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PrEP and the syndemic of substance use, violence, and HIV among female and male sex workers: a qualitative study in Kisumu, Kenya.
    Bazzi AR; Yotebieng K; Otticha S; Rota G; Agot K; Ohaga S; Syvertsen JL
    J Int AIDS Soc; 2019 Apr; 22(4):e25266. PubMed ID: 30983147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceptability of microbicidal vaginal rings and oral pre-exposure prophylaxis for HIV prevention among female sex workers in a high-prevalence US city.
    Peitzmeier SM; Tomko C; Wingo E; Sawyer A; Sherman SG; Glass N; Beyrer C; Decker MR
    AIDS Care; 2017 Nov; 29(11):1453-1457. PubMed ID: 28271718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
    Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
    Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Divergent Preferences for HIV Prevention: A Discrete Choice Experiment for Multipurpose HIV Prevention Products in South Africa.
    Quaife M; Eakle R; Cabrera Escobar MA; Vickerman P; Kilbourne-Brook M; Mvundura M; Delany-Moretlwe S; Terris-Prestholt F
    Med Decis Making; 2018 Jan; 38(1):120-133. PubMed ID: 28863752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Client experiences with "Dynamic Choice Prevention," a model for flexible patient-centred HIV prevention delivery in rural Eastern Africa.
    Camlin CS; Arunga T; Johnson-Peretz J; Akatukwasa C; Atwine F; Onyango A; Owino L; Kamya MR; Petersen ML; Chamie G; Kakande E; Kabami J; Balzer LB; Havlir DV; Ayieko J
    J Int AIDS Soc; 2024 Jul; 27(7):e26336. PubMed ID: 39020454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interest in HIV pre-exposure prophylaxis (PrEP) among adolescents and their caregivers in Malawi.
    Kidman R; Nachman S; Kohler HP
    AIDS Care; 2020 May; 32(sup2):23-31. PubMed ID: 32178529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study.
    Luecke EH; Cheng H; Woeber K; Nakyanzi T; Mudekunye-Mahaka IC; van der Straten A;
    J Int AIDS Soc; 2016; 19(1):20875. PubMed ID: 27247202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "I am still negative": Female sex workers' perspectives on uptake and use of daily pre-exposure prophylaxis for HIV prevention in South Africa.
    Eakle R; Bothma R; Bourne A; Gumede S; Motsosi K; Rees H
    PLoS One; 2019; 14(4):e0212271. PubMed ID: 30964874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barriers to Oral PrEP: A Qualitative Study of Female Sex Workers, PrEP Prescribers, Policymakers, and Community Advocates in Morocco.
    Moussa AB; Badahdah AM; Hidous K; Barakad R; Diallo F; Traoré M; Khodabocus N; Ebsen Treebhoobun A; Delabre R; Rojas Castro D; Ouarsas L; Karkouri M
    J Int Assoc Provid AIDS Care; 2024; 23():23259582241266691. PubMed ID: 39099547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Women's preferences for HIV prevention service delivery in pharmacies during pregnancy in Western Kenya: a discrete choice experiment.
    Mugambi ML; Odhiambo BO; Dollah A; Marwa MM; Nyakina J; Kinuthia J; Baeten JM; Weiner BJ; John-Stewart G; Barnabas RV; Hauber B
    J Int AIDS Soc; 2024 Jul; 27 Suppl 1(Suppl 1):e26301. PubMed ID: 38965978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The PrEP Care Continuum Among Cisgender Women Who Sell Sex and/or Use Drugs Globally: A Systematic Review.
    Glick JL; Russo R; Jivapong B; Rosman L; Pelaez D; Footer KHA; Sherman SG
    AIDS Behav; 2020 May; 24(5):1312-1333. PubMed ID: 31807973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The PEARL study: a prospective two-group pilot PrEP promotion intervention for cisgender female sex workers living in Baltimore, MD, U.S.
    Pelaez D; Weicker NP; Glick J; Mesenburg JV; Wilson A; Kirkpatrick H; Clouse E; Sherman SG
    AIDS Care; 2021; 33(sup1):1-10. PubMed ID: 33627006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acceptability of multiple modalities of pre-exposure prophylaxis (PrEP) among female sex workers in Tanzania: a mixed-methods study.
    Beckham SW; Mantsios A; Galai N; Likindikoki S; Mbwambo J; Davis W; Kerrigan D
    BMJ Open; 2022 Aug; 12(8):e058611. PubMed ID: 35977762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa.
    Pillay D; Stankevitz K; Lanham M; Ridgeway K; Murire M; Briedenhann E; Jenkins S; Subedar H; Hoke T; Mullick S
    PLoS One; 2020; 15(4):e0228620. PubMed ID: 32352969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acceptability and Predictors of Uptake of Anti-retroviral Pre-exposure Prophylaxis (PrEP) Among Fishing Communities in Uganda: A Cross-Sectional Discrete Choice Experiment Survey.
    Kuteesa MO; Quaife M; Biraro S; Katumba KR; Seeley J; Kamali A; Nakanjako D
    AIDS Behav; 2019 Oct; 23(10):2674-2686. PubMed ID: 30734882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.